1. Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?
- Author
-
Maaike Buskermolen, Jan Hendrik Richardus, Janko van Beek, Hannelore M Götz, Sabiena G. Feenstra, Karlijn Te Paske, Ewout Fanoy, Titia Kortbeek, Albert Vollaard, Public Health, and Virology
- Subjects
Adult ,Male ,Microbiology (medical) ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Pneumonia, Viral ,Disease ,Betacoronavirus ,Young Adult ,SDG 3 - Good Health and Well-being ,Recurrence ,Humans ,Medicine ,Letter to the Editor ,Pandemics ,Aged ,Retrospective Studies ,Aged, 80 and over ,Viral reactivation ,Reverse Transcriptase Polymerase Chain Reaction ,SARS-CoV-2 ,business.industry ,COVID-19 ,Middle Aged ,Virology ,Infectious Diseases ,RNA, Viral ,Female ,Coronavirus Infections ,business ,Viral load ,Follow-Up Studies - Abstract
For the first 3 months of COVID-19 pandemic, COVID-19 was expected to be an immunizing non-relapsing disease. We report a national case series of 11 virologically-confirmed COVID-19 patients having experienced a second clinically- and virologically-confirmed acute COVID-19 episode. According to the clinical history, we discuss either re-infection or reactivation hypothesis. Larger studies including further virological, immunological and epidemiologic data are needed to understand the mechanisms of these recurrences.
- Published
- 2021